The ability of glibenclamide and of gliclazide to act as protonophores has been studied in black lipid membranes made of glycerol monoleate as a function of pH and drug concentration. Protons may effectively be transported across lipid membranes with a maximum at a pH close to the pKa of the sulfamide (pKa of glibenclamide = 5.4). It is suggested therefore that hypoglycemic sulfonylureas may act in part as Ca2+ inward and H+ outward ionophores through plasma membranes of pancreatic B cells.In VitroJournal Articleinfo:eu-repo/semantics/publishe
Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion ...
Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion ...
AbstractThe effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplas...
fl-Cell-rich pancreatic islets, neurohypophyses, and adrenal medullae were used for exploring whethe...
Hypoglycaemic sulphonylureas, such as tolbutamide and gliclazide, provoke the translocation of calci...
Hypoglycemic sulfonylureas (e.g., gliclazide) are able to transport calcium across hydrophobic domai...
Sulfonylureas stimulate insulin secretion in type-2 diabetic patients by blocking ATP-sensitive (K(A...
The effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplasmic Ca2+...
Comm. Groupe de Contact "Pancréas Endocrine" du FRSM - Liège, 22.11.1980info:eu-repo/semantics/publi...
Sulfonylureas are widely used to stimulate insulin secretion in type 2 diabetic patients because the...
A decrease in membrane permeability to K+ is the first critical event occurring in pancreatic B-cell...
The stimulation of insulin secretion from the ß cells of the islets of Langerhans appears to be medi...
Sulfonylureas act as hypoglycemic agents by stimulating insulin secretion and improving insulin sens...
Sulfonylureas stimulate insulin secretion from pancreatic beta-cells by closing ATP-sensitive K+ (K(...
The stimulation of Ca2+ inflow into pancreatic islet cells resulting from either an increase in extr...
Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion ...
Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion ...
AbstractThe effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplas...
fl-Cell-rich pancreatic islets, neurohypophyses, and adrenal medullae were used for exploring whethe...
Hypoglycaemic sulphonylureas, such as tolbutamide and gliclazide, provoke the translocation of calci...
Hypoglycemic sulfonylureas (e.g., gliclazide) are able to transport calcium across hydrophobic domai...
Sulfonylureas stimulate insulin secretion in type-2 diabetic patients by blocking ATP-sensitive (K(A...
The effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplasmic Ca2+...
Comm. Groupe de Contact "Pancréas Endocrine" du FRSM - Liège, 22.11.1980info:eu-repo/semantics/publi...
Sulfonylureas are widely used to stimulate insulin secretion in type 2 diabetic patients because the...
A decrease in membrane permeability to K+ is the first critical event occurring in pancreatic B-cell...
The stimulation of insulin secretion from the ß cells of the islets of Langerhans appears to be medi...
Sulfonylureas act as hypoglycemic agents by stimulating insulin secretion and improving insulin sens...
Sulfonylureas stimulate insulin secretion from pancreatic beta-cells by closing ATP-sensitive K+ (K(...
The stimulation of Ca2+ inflow into pancreatic islet cells resulting from either an increase in extr...
Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion ...
Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion ...
AbstractThe effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplas...